HHS OIG: Labs with Questionably High Billing for Add-On Tests Warrant Further Scrutiny
Certain labs billed Medicare Part B for questionably high levels of add-on tests alongside COVID-19 tests in 2020.
Read MorePosted by Chris Wolski | Dec 29, 2022 | Compliance, Covid 19 |
Certain labs billed Medicare Part B for questionably high levels of add-on tests alongside COVID-19 tests in 2020.
Read MorePosted by Chris Wolski | Dec 28, 2022 | Specimen Collection & Handling |
Missing from the logistics discussion is how the healthcare industry will benefit, and, specifically, the transportation of lab samples.
Read MorePosted by Chris Wolski | Dec 27, 2022 | Covid 19 |
On December 22, 2022, the FDA issued emergency use authorizations (EUAs) for two additional OTC at-home COVID-19 Tests.
Read MorePosted by Chris Wolski | Dec 27, 2022 | Uncategorized |
IdentifySensors Biologics has completed preliminary clinical tests of positive COVID-19 samples using new graphene digital sensors.
Read MorePosted by Chris Wolski | Dec 27, 2022 | Covid 19 |
Minnesota has launched a telehealth test-to-treat program to ensure those who have tested positive for COVID have access to clinician care.
Read More